ECONOMY | 01.10.2020
Coronavirus: financial analysis XXVI
Limit situations, uncertainty and the psyche
The state in which we live, and which we still call a pandemic, gradually forces us to look beyond economics, politics or biology. Gonzalo de Cadenas-Santiago, director of macroeconomic and financial analysis at MAPFRE Economics, relies on the thesis of Karl Theodor Jaspers, the German philosopher and psychiatrist, to face the global social psychosis that lies ahead.
MIPS, the MAPFRE Behavioral Fund company that protects your brain
The Swedish company MIPS has created a built-in protection system to protect the brain from bumps and falls in both sporting and safety-critical situation. Luis García, equity manager and manager of the MAPFRE Behavioral Fund, analyzes the most heavily-weighted stock in the fund’s portfolio, which takes its cues from behavioral economics. In 2019, MIPS sold more than 14.2 million units to more than 100 helmet brands.
“The US election is going to consume investors’ attention over the next month”
The first Trump/Biden debate, which was described as vulgar and embarrassing by some media, tarnishes rather than clarifies the US elections and therefore increases uncertainty for the investor. Ismael García Puente, investment manager and fund selector for MAPFRE Gestión Patrimonial, analyzes this and other events that will determine market direction, and offers his recommendations to the retail investor.
“What investors should really be focusing on is what they are buying and at what price”
Jonathan Boyar, director of Boyar Value Group, with whom MAPFRE AM signed a collaboration agreement last year, discusses where he believes investors should be positioning their portfolios going forward. He also analyzes the investment case for IAC, which has a weight of around 2 percent in the MAPFRE AM US Forgotten Value portfolio.
- Coronavirus: financial analysis XXV
- Coronavirus: financial analysis XXIV
- Coronavirus: financial analysis XXIII
- Coronavirus: financial analysis XXII
- Coronavirus: financial analysis XXI
- Coronavirus: financial analysis XX
- Coronavirus: financial analysis XIX
- Coronavirus: financial analysis XVIII
- Coronavirus: financial analysis XVII
- Coronavirus: financial analysis XVI
- Coronavirus: financial analysis XV
- Coronavirus: financial analysis XIV
- Coronavirus: financial analysis XIII
- Coronavirus: financial analysis XII
- Coronavirus: financial analysis XI
- Coronavirus: financial analysis X
- Coronavirus: financial analysis IX
- Coronavirus: financial analysis VIII
- Coronavirus: financial analysis VII
- Coronavirus: financial analysis VI
- Coronavirus: financial analysis V
- Coronavirus: financial analysis IV
- Coronavirus: financial analysis III (Spanish)
- Coronavirus: financial analysis II (Spanish)
- Coronavirus: financial analysis I (Spanish)